The e (P4) phosphatase from Haemophilus influenzae functions in a vestigial NAD + utilization pathway by dephosphorylating nicotinamide mononucleotide to nicotinamide riboside. P4 is also the prototype of class C acid phosphatases (CCAPs), which are nonspecific 5′,3′-nucleotidases localized to the bacterial outer membrane. To understand substrate recognition by P4 and other class C phosphatases, we have determined the crystal structures of a substrate-trapping mutant P4 enzyme complexed with nicotinamide mononucleotide, 5′-AMP, 3′-AMP, and 2′-AMP. The structures reveal an anchor-shaped substrate-binding cavity comprising a conserved hydrophobic box that clamps the nucleotide base, a buried phosphoryl binding site, and three solvent-filled pockets that contact the ribose and the hydrogen-bonding edge of the base. The span between the hydrophobic box and the phosphoryl site is optimal for recognizing nucleoside monophosphates, explaining the general preference for this class of substrate. The base makes no hydrogen bonds with the enzyme, consistent with an observed lack of base specificity. Two solvent-filled pockets flanking the ribose are key to the dual recognition of 5′-nucleotides and 3′-nucleotides. These pockets minimize the enzyme's direct interactions with the ribose and provide sufficient space to accommodate 5′ substrates in an anti conformation and 3′ substrates in a syn conformation. Finally, the structures suggest that class B acid phosphatases and CCAPs share a common strategy for nucleotide recognition.
Introduction
The lipoprotein e (P4) 1,2 is a 28-kDa outer membrane acid phosphatase from Haemophilus influenzae, a common commensal inhabitant of the human nasopharynx and the etiologic agent of local and invasive infections in humans, particularly in children. 3, 4 The enzyme is a major component of the outer membrane and is highly conserved among H. influenzae strains. The high conservation and outer membrane location of e (P4) have motivated investigations of the enzyme as a potential vaccine component. Studies have shown that recombinant P4 (rP4) and rP4 mutant enzymes are highly immunogenic, that anti-rP4 antibodies exhibit bactericidal activity, and that immunization of mice with rP4 reduces nasal colonization of nontypeable H. influenzae strains. [5] [6] [7] The main biological role of e (P4) is to catalyze the conversion of nicotinamide mononucleotide (NMN) into nicotinamide riboside (NR) as part of a vestigial NAD + utilization pathway. 8, 9 H. influenzae lacks the full repertoire of enzymes needed for the de novo biosynthesis of NAD + ; therefore, it must obtain this essential cofactor from the host. The NAD + utilization pathway includes an uptake system that imports NAD + , NMN, and NR into the periplasm. Within the periplasm, the NAD + nucleotidase NadN catalyzes the hydrolysis of NAD + to generate NMN and AMP. NMN produced by NadN or imported by the uptake system is dephosphorylated to NR by e (P4). NadN also has NMN 5′-nucleotidase activity, but e (P4) has a higher efficiency for NMN and is thus thought to be the major catalyst for the production of NR for the pathway. 8 NR is then transported across the inner membrane into the cytosol by the NR-specific permease PnuC, where it is converted into NAD + by the bifunctional NR kinase/NMN adenylyltransferase NadR. 10 Although the biological function of e (P4) in NAD + utilization is well established, the structural basis for the recognition of NMN by P4 is unknown.
The larger context for the research described here is that e (P4) is the prototype of class C acid phosphatases (CCAPs). First recognized by Thaller et al. in 1998 as a family of related bacterial enzymes, CCAPs belong to the DDDD superfamily of phosphohydrolases and are defined at the primary structure level by the conserved bipartite sequence motif of [ 
IV]-[VAL]-D-[IL]-D-E-T-[VM]-L-X-[NT]-X(2)-Y and [IV]-[LM]-X (2)-G-D-[NT]-L-X-D-F (Asp residues of the DDDD motif in boldface)
. 11 In addition to e (P4), 1, 2, [12] [13] [14] several CCAPs, including those from Elizabethkingia meningoseptica (OlpA 15 ), Streptococcus equisimilis (LppC 16 ), Helicobacter pylori (HppA  17 ) , and Clostridium perfringens, 18, 19 have been characterized to various degrees. CCAPs are dimeric enzymes that exhibit phosphomonoesterase activity for commonly used aryl phosphate substrates such as p-nitrophenyl phosphate and 4-methylumbelliferyl phosphate. Among the physiologically relevant molecules that have been tested, the highest catalytic efficiencieshave been achieved with nucleoside 5′-monophosphates. CCAPs do not exhibit a strong base preference among this class of substrates. OlpA, LppC, 20 rP4 (vide infra), and the C. perfringens enzyme 18 also exhibit activity with nucleoside 3′-monophosphate substrates, but with lower efficiency than nucleoside 5′-monophosphate substrates. Thus, available in vitro data suggest that CCAPs function primarily as nonspecific 5′,3′-nucleotidases.
The structure of one CCAP (rP4) has been determined.
14 rP4 has a two-domain fold consisting of a core α/β domain (Fig. 1, blue) and an α-helical cap domain (Fig. 1, pink) . The four Asp residues of the DDDD motif are clustered around a Mg 2+ at the base of the active site (Fig. 1, yellow sphere) . The core domain fold indicates that rP4 belongs to the haloacid dehalogenase (HAD) structural superfamily. 22 The structure of rP4 complexed with the inhibitor tungstate provided insight into the identities of the nucleophile that attacks the substrate phosphoryl group (Asp64), the residue that protonates the leaving group (Asp66), and the side chains that stabilize the substrate phosphoryl group (Lys161 and Thr124). However, the residues that interact with the nonphosphoryl groups of substrates have not been identified. Thus, the structural elements that enforce the preference for nucleoside monophosphates are unknown. Furthermore, the question of how CCAPs achieve the dual recognition of nucleoside 5′-monophosphate and nucleoside 3′-monophosphate remains unanswered.
Within this context, we initiated a structure-based study of substrate recognition with the goals of understanding how rP4 binds its known biological substrate (NMN) and, more generally, elucidating the To this end, we have determined the high-resolution crystal structures of a substrate-trapping mutant of rP4 complexed with NMN, 5′-AMP, 3′-AMP, and 2′-AMP, as well as a structure of rP4 complexed with the product inorganic phosphate (P i ) ( Table 1) . The structures and the accompanying kinetic data provide insight into the basis of the nucleotidase activities of P4 and other CCAPs.
Results
Structures of D66N complexed with NMN and 5′-AMP Crystal structures of rP4 complexed with NMN and 5′-AMP were determined to understand how the enzyme recognizes nucleoside 5′-monophosphate substrates. D66N, a mutant of rP4 in which the residue that protonates the leaving group (Asp66) has been changed to Asn, was used for the structure determination of enzyme-substrate complexes. Structures of D66N complexed with NMN ( Fig. 1 ) and 5′-AMP were determined at high-resolution limits of 1.35 Å and 1.55 Å, respectively ( Table 1 ). The electron density maps at these resolutions allowed an unambiguous determination of the conformations of the bound substrates, enumeration of enzyme-substrate interactions, and identification of water molecules involved in substrate binding ( Fig. 2a and b) .
NMN and 5′-AMP bind in an anchor-shaped cavity located at the junction of the α/β core domain and the cap domain, as shown for 5′-AMP in Fig. 3a . NMN and 5′-AMP adopt identical conformations when bound to the enzyme (Fig. 4) . Based on the nomenclature described by Saenger, the ribose in each case displays an asymmetrical twist with major C 3′ -endo pucker and minor C 2′ -exo pucker ( 3 T 2 ). 25 The bases adopt an anti orientation about the glycosyl bond.
The substrate phosphoryl group occupies the wellknown phosphoryl binding site of HAD superfamily enzymes (Fig. 4) . In both structures, the phosphoryl group interacts with the active site Mg 2+ , the conserved residues Thr124 and Lys161, and the backbone N-H group of Asn66. These interactions are identical with those observed in the structure of rP4 complexed with P i (Fig. 2e) . Furthermore, the substrate phosphoryl sits above the nucleophilic O atom of Asp64 in an orientation suggestive of backside nucleophilic attack. In particular, the nucleophilic O atom is poised 3.0 Å from the P atom, and the angle formed by the nucleophile, P, and O 5′ is 179°. Finally, the O atom of the scissile bond forms a hydrogen bond with Asn66 (2.8 Å). This interaction is consistent with Asp66 functioning as the acid that protonates the leaving group. The ribose moieties of NMN and 5′-AMP form identical interactions with rP4 (Fig. 4) . In each structure, the ribose is oriented such that the C 2′ -C 3′ locus contacts the pyrrole ring of Trp91, while the opposite edge of the ring (i.e., O 4′ ) points towards a large solvent-filled pocket on the right-hand side of the active site (Fig. 3a, pocket 1) . The hydroxyl groups of the ribose occupy a second smaller pocket on the left side (Fig. 3a , pocket 2). Within pocket 2, the 2′-hydroxyl group forms a water-mediated hydrogen bond with Glu131 (Fig. 4) .
Finally, the bases of NMN and 5′-AMP bind in an aromatic box formed by Phe86, Trp91, and Tyr221 (Fig. 4) . The first two residues are part of the helixloop-helix substructure of the cap domain, while Tyr221 is located in the loop that follows the last strand of the core domain (Fig. 1 ). Phe86 and Tyr221 form the sides of the box, while Trp91 forms the floor. In both complexes, the base stacks in parallel between Phe86 and Tyr221, forming an aromatic sandwich. Trp91 contacts the C 5 -C 6 locus of the NMN nicotinamide and the pyrrole ring of adenine. The hydrogenbonding groups of the bases are directed towards a In each panel, the cage (cyan for the ligand; silver for protein side chains) represents a simulated-annealing σ A -weighted F−F c omit map contoured at 3.0σ. Prior to map calculation, the ligand, surrounding residues, and water molecules were removed, and simulated-annealing refinement was performed using PHENIX.
solvent-filled cavity at the top of the active site (Fig.  3a, pocket 3) . As a result, neither base forms direct hydrogen bonds with the enzyme, but there are water-mediated hydrogen bonds with Gln79, Asn220, and Glu225.
Structures of D66N complexed with 3′-AMP and 2′-AMP
Structures of D66N complexed with 3′-AMP and 2′-AMP were determined to understand how rP4 and other CCAPs accommodate nucleoside monophosphate substrates differing in the position of the phosphoryl group on the ribose. Both electron density maps exhibited a strong feature representing the bound substrates. The quality of the 2′-AMP map (Fig. 2d) rivaled those of NMN and 5′-AMP. Although the 3′-AMP map exhibited a lower quality, the locations of the adenine ring, phosphoryl group, 2′-hydroxyl, and O 4′ were unambiguous (Fig. 2c) . The density for the C 5′ -O 5′ bond of the ribose was weaker and suggested the same conformation as in 2′-AMP. The weaker density for 3′-AMP also suggested that the occupancy of the ligand is less than 1.0; refinement of the occupancy resulted in a value of 0.81.
The conformations of 2′-AMP and 3′-AMP differ substantially from that of 5′-AMP (Fig. 5) . In both 2′-AMP and 3′-AMP, the ribose adopts the C 2′ -endo pucker ( 2 E), and the base is in a syn orientation. We note that the C 2′ -endo pucker is favored for syn nucleosides. 25 The syn conformation is stabilized by an intramolecular hydrogen bond between N 3 and O 5′ (2.9 Å in 3′-AMP and 2.8 Å in 2′-AMP). We note that this type of interaction is commonly found in syn nucleotides. 25 As observed with 5′-AMP, the bases of 2′-AMP and 3′-AMP bind in the aromatic box, with the N 6 -N 7 edge directed towards pocket 3 ( Fig. 3b and c) . However, the ribose rings of 2′-AMP and 3′-AMP are oriented with O 4′ pointing towards the left into pocket 2, which is the reverse of the orientation of the bound 5′ substrates (compare Fig.  3b and c to Fig. 3a) .
Finally, there is a difference between the position of the phosphoryl group of 2′-AMP and the position of the phosphoryl group of the other substrates (Fig.  5b) . The phosphoryl group of 2′-AMP is shifted by 1.8 Å from the expected site such that the P atom is 4.3 Å from the nucleophilic O atom of Asp64, which is obviously not optimal for catalysis. As a result of the shift, the phosphoryl group does not form the expected interactions with the conserved residues Thr124 and Lys161.
Kinetic characterization of rP4
The catalytic efficiencies (k cat /K m ) of rP4 for certain nucleoside monophosphate substrates were estimated using steady-state kinetic assays. NMN, 5′-AMP, 3′-AMP, and 2′-AMP were used as substrates; the results are summarized in Table 2 . Among the substrates tested, the enzyme has the highest efficiency for NMN, followed by 5′-AMP, 3′-AMP, and 2′-AMP. The efficiency for NMN is only 2.5 times that for 5′-AMP, suggesting that rP4 does not Fig. 4 . Recognition of the nucleoside 5′-monophosphate substrates (a) NMN and (b) 5′-AMP (stereographic views). In both panels, the substrate is represented in yellow sticks, and Mg 2+ is depicted as a yellow sphere. Secondary structural elements of the core and cap domains are shown in blue and pink, respectively, and residues of the aromatic box are shown in green.
exhibit a strong preference for NMN over other nucleoside 5′-monophosphatases. Comparing the data for the AMP substrates, we found that rP4 exhibits only a 2-fold preference for 5′-AMP over 3′-AMP. 2′-AMP is the poorest substrate tested, with a 20-fold lower efficiency than 5′-AMP. Thus, like some other CCAPs, it is reasonable to classify rP4 as a dual 5′,3′-nucleotidase.
Discussion Structural basis of substrate recognition
The main aim of our work is to provide structurebased insight into the substrate preference and promiscuity of rP4 and CCAPs closely related to rP4. CCAPs are somewhat selective in the sense that the in vivo substrates are thought to be nucleoside monophosphates. For example, genetic and molecular studies suggest that NMN is a biological substrate for e (P4). 9 Although the in vivo substrates of other CCAPs have not been similarly identified, available in vitro kinetic data suggest nucleoside monophosphates as biologically relevant substrates. On the other hand, CCAPs are generally promiscuous with regard to the identity of the base and whether the phosphoryl is In both panels, the substrate is represented in yellow sticks, and Mg 2+ is depicted as a yellow sphere. Secondary structural elements of the core and cap domains are shown in blue and pink, respectively, and residues of the aromatic box are shown in green. In (b), the location of a normal phosphoryl binding site is indicated by the phosphate ion shown in lines and labeled P i . The basis for the preference for nucleoside monophosphates is evident from the D66N complexes. The aromatic box is well suited for binding the aromatic ring systems of nucleotides. In particular, the box provides two aromatic residues that stack in parallel, with the base forming a sandwich. Furthermore, the span between the aromatic box and the phosphoryl binding pocket is optimal for nucleoside monophosphates.
The structures also provide insight into substrate promiscuity with respect to the base. The base is aligned in the aromatic box such that the hydrogenbonding groups point into a solvent-filled pocked. As a result, there are no direct hydrogen bonds with the enzyme implying low base selectivity. Indeed, we have shown here that the catalytic efficiency of rP4 for 5′-AMP rivals that for NMN. These results imply that P4 is not tuned to exclusively recognize NMN, and that the enzyme may have other biological functions beyond NAD + utilization, such as acquiring P i from nucleoside monophosphates found in the bacterium's environment.
The D66N structures also shed light on how rP4 achieves the dual recognition of 5′-nucleoside monophosphate and 3′-nucleoside monophosphate, a characteristic of some CCAPs. The 5′ substrates bind with the base in an anti conformation, whereas 3′-AMP adopts a syn conformation. The somewhat higher catalytic efficiency of 5′ substrates likely reflects the lower conformational energy of the anti conformation. The two solvent-filled pockets flanking the ribose appear to be important for the enzyme's ability to bind both types of substrates. These pockets minimize the enzyme's direct interactions with the ribose and provide sufficient space to accommodate the different ribose orientations. Indeed, the ribose occupies the widest part of the active site (Fig. 3) . Thus, the open active site of rP4 appears to underlie both the weak base specificity and the dual recognition of 5′-nucleoside monophosphate and 3′-nucleoside monophosphate.
The structure of D66N complexed with 2′-AMP further demonstrates the ability of the active site to bind different nucleoside monophosphates. The structure is unusual in that the phosphoryl is shifted away from the catalytic Asp into a solvent-filled pocket and is thus not aligned optimally for catalysis. This conformation perhaps represents a nonproductive complex. As discussed by Cornish-Bowden, nonproductive binding of the substrate is a form of competitive inhibition, and the measured values of V max and K m are lower than expected by an unknown and typically immeasurable amount. 26 Nevertheless, V max /K m does provide a correct measure of the catalytic properties of the enzyme in such cases. 26 We found that the apparent catalytic efficiency of rP4 for 2′-AMP is substantially lower (10-50 times) than those for the other substrates tested, indicating that it is a poor substrate. Regardless of whether the observed conformation represents nonproductive substrate binding, the rP4/2′-AMP structure provides another illustration of how the open active site plays a role in binding different nucleoside monophosphate ligands.
Connections with other CCAPs and class B acid phosphatases
Sequence conservation suggests that the rP4 complexes reported here are representative of other CCAPs. The residues of the phosphate binding pocket (Asp64 Asp66, Lys161, and Thr124) are highly conserved in the HAD superfamily, and, as expected, these residues are highly conserved among CCAPs. In fact, Asp64, Asp66, and Lys161 are invariant among the CCAPs, and Thr124 appears as Ser (a conservative substitution) in some CCAPs. Residues of the aromatic box are also highly conserved. Tyr221 appears to be universally conserved among CCAPs. An aromatic ring in the form of Phe, Tyr, Trp, or His is always present at the residue corresponding to rP4 Phe86. Thus, all CCAPs appear to have residues capable of forming an aromatic sandwich with the nucleotide base. Finally, the floor of the box (Trp91) is almost invariant; substitution with Phe (a conservative change) is observed in some CCAP sequences. Thus, we suggest that the structures reported here provide a model for understanding substrate recognition in other CCAPs.
The rP4 structures also reveal a new relationship between CCAPs and the related phosphatases known as class B acid phosphatases (CBAPs). The D66N/5′-AMP complex is reminiscent of the structure of the CBAP AphA complexed with the 5′-AMP analog 9-
27 ]. CBAPs also belong to the DDDD superfamily, and AphA is regarded as the prototype of the family. CBAPs have a bipartite sequence motif that is similar to that of CCAPs, and, like CCAPs, class B enzymes also show a preference for nucleoside 5′-monophosphate and nucleoside 3′-monophosphate substrates. Although rP4 and AphA share a common HAD superfamily core domain, their sequences have negligible similarity outside of the bipartite sequence motif (13% overall identity), and their cap domains have different folds. The latter difference is related to the different quaternary structures of the two enzymes (dimer for CCAPs and tetramer for CBAPs).
Despite the different cap domain structures, AphA and P4 exhibit commonalities in substrate recognition. In particular, the adenine ring of PMEA packs into a hydrophobic pocket that is similar to the aromatic box of rP4 (Fig. 6) . The hydrophobic pocket of AphA consists of Leu71, Tyr193, and Phe56, which are analogous to the rP4 aromatic box residues Phe86, Tyr221, and Trp91, respectively. Note also that the adenine rings have nearly identical orientations in the two structures. We thus suggest that CBAPs and CCAPs share a common strategy for nucleotide recognition.
Materials and Methods

Subcloning and mutagenesis
Previous structural studies of rP4 used a recombinant enzyme lacking a polyhistidine affinity tag, but the purification of that enzyme was inefficient, 13 and crystallization was not highly reproducible. Therefore, for this work, an rP4 construct encoding the enzyme fused to a C-terminal hexahistidine tag was created to aid purification. The hel gene was subcloned into pET20b using NcoI and XhoI sites such that the N-terminal signal sequence was replaced with the pelB leader sequence from Erwinia chrysanthemi, and the N-terminal Cys of the mature protein was replaced with Met. As a result, the rP4 protein used here contains a C-terminal hexahistidine tag, is free of lipid modification, and is targeted to the Escherichia coli periplasm.
A site-directed mutant of rP4 in which the residue that protonates the leaving group (Asp66) is changed to Asn (D66N) was created to determine the crystal structures of enzyme-substrate complexes. We note that an analogous strategy has been used to trap substrate complexes of other phosphatases. 28, 29 The mutation was introduced into the aforementioned plasmid using the QuickChange kit (Stratagene) and confirmed by DNA sequencing.
Expression and purification of rP4
The rP4 pET20b plasmid was transformed into E. coli BL21AI cells and plated on LB medium containing ampicillin (50 μg/mL). A single colony of the transformant was picked and used to inoculate 1 L of culture. The protein was expressed via autoinduction 30 at 37°C, with constant shaking at 300 rpm. The cells were harvested by centrifugation at 3500 rpm for 30 min at 4°C and resuspended in 20 mM phosphate, 20 mM imidazole, and 500 mM NaCl at pH 7.0. The cell pellet was flash frozen in liquid nitrogen and stored at −80°C.
Frozen cells were thawed at 4°C and ruptured using a French press at 1000 psi. Unbroken cells and cellular debris were removed by centrifugation for 60 min at 17,500 rpm and 4°C. The supernatant was collected and subjected to a second centrifugation step (30 min, 17,500 rpm, 4°C). The resulting supernatant was used for further purification by immobilized metal-ion affinity chromatography (Ni 2+ -charged HiTRAP; GE Healthcare), followed by cation-exchange chromatography (HiTRAP SP; GE Healthcare). The purified enzyme was dialyzed into 50 mM sodium acetate, 50 mM NaCl, and 2.5 mM MgCl 2 at pH 6.0. The sample was concentrated to 2-5 mg/mL (based on the bicinchoninic acid assay; Pierce) using a centrifugal ultrafiltration device (cutoff, 10 kDa).
Expression and purification of D66N
The D66N mutant plasmid was transformed into E. coli BL21(DE3) cells and plated on LB medium containing ampicillin (50 μg/mL). A single colony of the transformant was picked and used to inoculate a 10-mL starter culture containing ampicillin (50 μg/mL). After overnight growth at 37°C with shaking at 250 rpm, the starter culture was used to inoculate 1 L of LB medium supplemented with ampicillin (50 μg/mL). The culture was then grown at 37°C with shaking at 250 rpm until the optical density at 600 nm had reached 0.6. Protein expression was induced by adding isopropyl β-D-thiogalactoside (0.5 mM), and the culture was incubated for 8 h at 25°C with shaking at 200 rpm. The expressed protein was purified as described above for rP4. After purification, the sample was dialyzed overnight into 50 mM sodium acetate and 50 mM NaCl at pH 6.0 and concentrated to 10 mg/mL.
Crystallization and preparation of enzyme-ligand complexes
Crystallization trials of rP4 and D66N were performed at 20°C using the sitting-drop method, with drops formed from 2 μL of enzyme solution and 2 μL of reservoir solution. Initial crystallization conditions were identified using commercially available screens (Hampton Research). Promising results were obtained with reservoirs containing ammonium citrate and polyethylene glycol (PEG) 3350. After optimization, diffraction-quality crystals with a hexagonal external morphology were grown over reservoirs containing 0.05-0.2 M ammonium citrate, 0.05-0.15 mM MgCl 2 , and 18-28% (wt/vol) PEG 3350 in the pH range 6.8-7.2. The best rP4 crystals typically grew in 18-23% (wt/vol) PEG 3350, whereas a higher concentration of 23-28% (wt/ vol) PEG 3350 was used for crystallization of D66N. The typical protein concentrations used for optimal crystal growth were 1-3 mg/mL for rP4 and 8-10 mg/mL for D66N. Crystals of the D66N-substrate complexes were obtained by soaking, as follows. Stock solutions of the substrates were prepared in water, and the pH was adjusted to 6.0. D66N crystals were cryoprotected in 28-30% PEG 3350, 0.1 M ammonium citrate buffer (pH 7.0), and 20% PEG 200. The cryoprotected crystals were transferred to a solution of the cryobuffer supplemented with 5-20 mM substrate and 100-200 mM MgCl 2 . The soaking time was in the range of 5-45 min.
Crystals of rP4 complexed with P i were also obtained by soaking. A stock solution of potassium phosphate (100 mM KH 2 PO 4 , pH 6.0) was first prepared. Next, crystals of rP4 were cryoprotected at room temperature in 23-28% (wt/vol) PEG 3350, 0.1 M ammonium citrate buffer (pH 7.0), and 20% PEG 200. The cryoprotected crystals were transferred to a solution of the cryobuffer supplemented with 25 mM P i and 200 mM MgCl 2 . After 30 min, the crystals were picked up with Hampton loops and plunged into liquid nitrogen.
Structure determination
X-ray diffraction data sets were collected at Advanced Light Source beamline 4.2.2 and Advanced Photon Source beamline 24-ID-C ( Table 1 ). The data sets were processed with HKL2000. 31 The crystals belonged to space group P6 5 22 with unit cell lengths of a = 98 Å and c = 107 Å, one molecule in the asymmetrical unit, 54% solvent, and a V m of 2.65 Å 3 /Da. 32, 33 We note that this form is different from the tetragonal one used in our earlier work.
14 Initial phases were estimated using molecular replacement as implemented in PHASER, 34 with the search model derived from a previously determined rP4 structure (PDB code 3ET4 14 ). Coot 35 was used for model building, and PHENIX 36 was used for refinement. A common set of test reflections (5%) was used for refinement calculations. For each structure, the B-factor model used during the initial rounds of refinement consisted of an isotropic B-factor for each nonhydrogen atom and TLS refinement, with one TLS group corresponding to the protein chain. Anisotropic B-factors were used during the final few rounds of refinement of the NMN and P i complexes. The introduction of anisotropic B-factors decreased R free by 0.08 for the NMN complex and by 0.06 for the P i complex.
Kinetic characterization
Steady-state enzymatic activity was assessed at 25°C using a discontinuous assay that measures the production of P i . 37, 38 The assay buffer consisted of 100 mM sodium acetate, and 1 mM MgCl 2 at pH 5.5. For each substrate concentration, the reaction was stopped using the malachite green reagent after reaction times of 15 s, 75 s, 135 s, and 195 s, and the citrate color development reagent (34% sodium citrate, wt/vol) was added 60 s after stopping each reaction. After 30 min, the P i concentrations were determined spectrophotometrically at 625 nm by reference to a standard curve constructed from solutions of known P i concentration. The initial rate was estimated by fitting the data from the four time points to a line. Apparent values of K m and V max were estimated by fitting the initial rate data to the Michaelis-Menten equation using Origin 8 software.
PDB accession codes
Atomic coordinates and structure factor amplitudes have been deposited in the PDB 39 with accession codes 3OCU (NMN), 3OCV (5′-AMP), 3OCW (3′-AMP), 3OCX (2′-AMP), and 3OCY (P i ).
